Anthony Quinn

Track

Insider profile

Currently holds positions in Kaleido Biosciences Inc and Spyre Therapeutics Inc

Performance

Overall performance
2.5
Performance over holding periods
2.5
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 51% 68% 82%
Transactions
16 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director Kaleido Biosciences Inc None -
President and Chief Executive Officer, Director Spyre Therapeutics Inc Oct. 10, 2019 -
President, Chief Executive Officer, Director Spyre Therapeutics Inc July 1, 2018 - Oct. 10, 2019
Interim Chief Executive Officer, Director Spyre Therapeutics Inc July 18, 2017 - July 1, 2018
Director, Interim Chief Medical Officer Spyre Therapeutics Inc April 1, 2017 - July 1, 2017
Independent Director Spyre Therapeutics Inc March 1, 2016 - April 1, 2017
Anthony Quinn's trades of Generation Bio Co's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
408.82
Quantity 95,245 -43.4%
Value US$2,710,862
Transaction date
Purchase
Price
178.24
Quantity 4,968 +12.6%
Value US$2,272,906
Transaction date
Purchase
Price
328.52
Quantity 56,910 +48.1%
Value US$4,147,995
Transaction date
Planned purchase
Price
3.70
Quantity 43,108 +15.7%
Value US$159,500
Transaction date
Planned purchase
Price
4.75
Quantity 165,000 +44.2%
Value US$783,750
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-14 2025-01-13
B Purchase
95,245 -43.4%
408.82
US$2,710,862 		95,245 -43.4% 408.82 US$2,710,862
2025-01-14 2025-01-10
B Purchase
4,968 +12.6%
178.24
US$2,272,906 		4,968 +12.6% 178.24 US$2,272,906
2023-12-05 2023-12-01
B Purchase
56,910 +48.1%
328.52
US$4,147,995 		56,910 +48.1% 328.52 US$4,147,995
2022-03-18 2022-03-16
B Purchase
80,079 +17.0%
2.34
US$187,705 		80,079 +17.0% 2.34 US$187,705
2022-03-15 2022-03-15
B Purchase
42,417 +9.8%
1.86
US$78,942 		42,417 +9.8% 1.86 US$78,942
2022-03-15 2022-03-14
B Purchase
67,472 +18.6%
1.93
US$130,221 		67,472 +18.6% 1.93 US$130,221
2022-03-15 2022-03-11
B Purchase
34,777 +10.6%
2.06
US$71,780 		34,777 +10.6% 2.06 US$71,780
2021-12-13 2021-12-10
PP Planned purchase
10,526 +3.3%
3.75
US$39,472 		10,526 +3.3% 3.75 US$39,472
2021-12-13 2021-12-09
PP Planned purchase
43,108 +15.7%
3.70
US$159,500 		43,108 +15.7% 3.70 US$159,500
2020-05-04 2020-04-30
PP Planned purchase
165,000 +44.2%
4.75
US$783,750 		165,000 +44.2% 4.75 US$783,750
2019-06-14 2019-06-14
B Purchase
5,282 +1.5%
6.23
US$32,913 		5,282 +1.5% 6.23 US$32,913
2019-06-14 2019-06-13
B Purchase
14,406 +4.3%
6.17
US$88,836 		14,406 +4.3% 6.17 US$88,836
2019-06-14 2019-06-12
B Purchase
12,217 +3.8%
6.11
US$74,705 		12,217 +3.8% 6.11 US$74,705
2019-05-22 2019-05-22
B Purchase
3,809 +1.2%
6.86
US$26,128 		3,809 +1.2% 6.86 US$26,128
2019-05-22 2019-05-21
B Purchase
13,794 +4.5%
6.89
US$94,981 		13,794 +4.5% 6.89 US$94,981
2019-05-22 2019-05-20
B Purchase
8,989 +3.0%
6.56
US$58,923 		8,989 +3.0% 6.56 US$58,923
2019-05-17 2019-05-17
B Purchase
6,218 +2.2%
6.65
US$41,335 		6,218 +2.2% 6.65 US$41,335
2019-05-17 2019-05-16
B Purchase
5,520 +1.9%
6.83
US$37,691 		5,520 +1.9% 6.83 US$37,691
2019-05-17 2019-05-15
B Purchase
6,256 +2.3%
6.76
US$42,269 		6,256 +2.3% 6.76 US$42,269
2019-05-17 2019-02-15
PP Planned purchase
719 +0.3%
7.10
US$5,103 		719 +0.3% 7.10 US$5,103